11 May 2026
A newly published clinical study evaluated Ruby-O® BPL-O3™, Naturmega’s bonded phospholipid omega-3 platform.
Despite a lower daily dose (825 mg EPA + DHA), Ruby-O® Balance achieved up to 3x greater triglyceride target attainment compared to standard triglyceride fish oil, along with significant improvements in Omega-3 Index.